Af­ter re­vamp­ing R&D in a glob­al shake­up, Bay­er prep­ping new labs for an ex­pan­sion in can­cer re­search at MIT

At Bay­er, Pitts­burgh is out, Cam­bridge, MA is in.

As part of a glob­al shake­up that is cost­ing 12,000 jobs, Bay­er re­cent­ly an­nounced that it will shut down its old US HQ in Penn­syl­va­nia, ax­ing hun­dreds of staffers. And that is hap­pen­ing while R&D is tak­ing a big hit at the Ger­man multi­na­tion­al, with 900 re­searchers get­ting cut as Bay­er com­pletes the trou­ble­some Mon­san­to ac­qui­si­tion.

But that doesn’t mean they’ve stopped adding re­search staff in the fields where they plan to grow.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER